Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 52,266 |
|
|||||
| News | - | ||||||
| Day High | 1.09 | Low High |
|||||
| Day Low | 1.02 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Yubo International Biotech Ltd (QB) | YBGJ | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.01 | 0.97% | 1.04 | 15:08:53 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.04 | 1.02 | 1.09 | 1.04 | 1.03 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11 | 52,266 | US$ 1.0205 | US$ 53,339 | - | 0.0651 - 1.09 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 12:36:12 | 100 | US$ 1.04 | USD |
Yubo International Biotech Ltd (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 124.61M | 119.82M | 12.85M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Yubo International Biotech (QB) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/20/2024 | 07:15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/13/2024 | 15:06 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
| 11/20/2023 | 05:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 8/11/2023 | 15:05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical YBGJ Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.94 | 1.09 | 0.90 | 0.9994968 | 32,384 | 0.10 | 10.64% |
| 1 Month | 0.899 | 1.09 | 0.65 | 0.916099 | 50,980 | 0.141 | 15.68% |
| 3 Months | 0.6485 | 1.09 | 0.11 | 0.5004309 | 65,617 | 0.3915 | 60.37% |
| 6 Months | 0.2124 | 1.09 | 0.11 | 0.5013471 | 56,334 | 0.8276 | 389.64% |
| 1 Year | 0.085 | 1.09 | 0.0651 | 0.4780812 | 38,251 | 0.955 | 1,123.53% |
| 3 Years | 0.70 | 1.10 | 0.03 | 0.4156965 | 19,717 | 0.34 | 48.57% |
| 5 Years | 1.82 | 3.98 | 0.03 | 0.5462756 | 14,124 | -0.78 | -42.86% |
Yubo International Biotech (QB) Description
| Yubo International Biotech Limited (together with its subsidiaries, "Yubo") is a U.S. holding company. Through its wholly-owned subsidiaries, and certain contractual arrangements with a PRC entity, Yubo provides research and development and application of endometrial stem cells. Yubo is committed to building the first public endometrial stem cell repository in the world. Yubo offers its products and services under the brand "VIVCELL". Yubo's product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. Yubo also offers stem cell related services including cell testing and health management consulting services. |
